The Mayo Clinic PCI risk score identifies ACS patients at risk of in-hospital mortality, bleeding, contrast associated-AKI, and #stroke. #AHAJournals @antoniolandii @AndreaZito66 @mandeep_mayo @DFCapodanno @vlgmrc https://t.co/8Di72aTjXQ

Fractional flow reserve or OCT to guide management of complex and noncomplex angiographically intermediate coronary stenosis #REC @AndreaZito66 @BURZOTTA_F. https://t.co/NujzUhlylF

Implications of platelet counts and their dynamics in patients hospitalized with acute coronary syndromes, using MATRIX trial data. Read this article published in @RevEspCardiol by @AndreaZito66 @vlgmrc https://t.co/gJFwAZ93LF

Guidelines recommend using imaging in complex #PCI . New meta-analysis of RCTs supports this and allows estimate the potential benefit of #IVUS or #OCT: NUMBER NEEDED TO TREAT is 11 pts to prevent one TVF in #LM PCI and of 27 in #bifurcation PCI.  https://t.co/NKibFjPC0p

Fractional flow reserve or OCT to guide management of complex and noncomplex angiographically intermediate coronary stenosis #REC #AheadOfPrint @AndreaZito66 @BURZOTTA_F. https://t.co/JqhEujZUPb

Now we know: if you embarque into bifurcation stenting and want/need to treat LARGE side-branches, POT-KISS-POT is associated with better OCT results. Great 🙏 & 👋 to Gemelli’s interventional cardiology team !!!!! #CRT2025 #JACCINT

Thrilled to share the #JACCINT LBCT Simultaneous Publication at #CRT2025 in Washington DC!!!! A special thanks to my mentors @BURZOTTA_F, Carlo trani and all the team. https://t.co/PzfyadSJcN

Proud that our review is actually the most read article in 2024 on Circulation: Cardiovascular Interventions https://t.co/75NlxqMd2p @BURZOTTA_F @CristinaAuri17 @enromagnoli @bianchinifra92 @Mattialunardi @Emiliano_Bi2 @AndreaZito66

Balloon-Expandable vs Self-Expanding Valves for Transcatheter Treatment of Sievers Type 1 Bicuspid Aortic Stenosis: @JACCJournals 🥸 We recently did a TAVR on Sievers Type 0 without procedural complications. 😱 This is a nice study 👇👇👇👇

#GISE45 #JACCINT: Current-generation BEVs & SEVs proved similar technical success & midterm clinical efficacy in Sievers type 1 BAV stenosis. Compared to SEVs, BEVs were assoc w/ less permanent pacemaker implantation & moderate or greater paravalvular regurgitation

Thirty years ago, the late great 🇬🇧 statistician Douglas Altman wrote what would go on to become one of the most highly cited editorials in medicine: "The scandal of poor medical research" If he were alive today, I suspect he'd feel things are even worse https://t.co/oQRXq9WNU6

After years… we have finally been able to summarize all the tricks we endorsed or developed… Indeed, we STRONGLY BELIEVE that the benefit of transcatheter procedures like #PCI #Impella #ECMO #TAVR often depends on how we deal with the arterial access!!! Thank you to the TEAM!

Large-bore access management is crucial in structural heart interventions. Check out our latest review in @CircIntv to explore tips to prevent vascular complications! https://t.co/NTOjcyUrhx @BURZOTTA_F @bianchinifra92 @CristinaAuri17 @AndreaZito66 @Emiliano_Bi2 @Mattialunardi

Searching for insights into managing NSTE-ACS and multivessel CAD with so little randomized evidence? Check out our latest work, from the Gemelli Hospital cath lab team! Thanks to all the coauthors and a special one to @BURZOTTA_F https://t.co/3WLwhl8KnS @IJCardio

After #TAVR with current-generation THVs in Sievers type 1 BAV stenosis, moderate or severe paravalvular regurgitation occurred in about 4% of cases and was associated with an increased risk of major adverse events during follow-up. https://t.co/ygThf6kDLf #JACCINT #vhdAS #MACE

Predictors of PVL in Sievers type 1 bicuspid #TAVR @JACCJournals #JACCINT: virtual raphe ring, annular/LVOT Ca, SEV, supra-annular implant https://t.co/L3dzF6hPxC

Happy to be part of the next #ESC Council on Stroke nucleus! ⤵️

Fractional Flow Reserve versus Optical Coherence Tomography to guide Revascularization of Intermediate Coronary Stenoses: read the FORZA trial on #EHJ! #coronary #stenosis #MACE #OCT #FFR #EHJ #cardiotwitter @ESC_journals @escardio https://t.co/jDtC365TV1

Fifty years since Gould's seminal work on coronary autoregulation, we are honoured to contribute with the first proof of coronary autoregulation in humans. https://t.co/cqL9Ukb1He This advances our understanding of coronary physiology significantly. @NEJM @BernardBruyne

#FORZA trial: 5-year follow-up Thrilled to share our manuscript just published in the European Heart Journal @ehj_ed 📉 For the management of patients with angiographically intermediate coronary stenosis, #OCT and #FFR guidance had a similar risk of MACE https://t.co/zCyEED7iGv